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Supporting Information 
 
All reagents were used as received unless otherwise noted. Solvents were purified under 
nitrogen using a solvent purification system (Innovative Technology, Inc. Model # SPS-
400-3 and PS-400-3). Tris(dibenzylideneacetone)-dipalladium (Pd2dba3) was purchased 
from Sigma Aldrich and was stored in a glovebox  and on the benchtop. All reactions 
were conducted under an atmosphere of nitrogen with magnetic stirring in flame-dried or 
oven-dried (120 ˚C) glassware. All acyclic allenes were made according to literature 
precedent from the terminal alkyne and aldehyde.1 Cyclic allenes were made according to 
literature precedent from the respective ketone..2 Ligand 6 (IPr*OMe) was purchased from 
Strem and was stored in a glovebox. NHC Ligands 4 (IMes·HCl) and 5 (IPr·HCl) were 
purchased from Sigma-Aldrich and stored and weighed in a glovebox. Ligand DP-IPr 
was prepared according to literature procedure.3 Dimethylphenylsilane and 
dimethylbenzylsilane (purchased from Sigma-Aldrich) were used as received. A solution 
of tetra-n-butylammonium (TBAF, 1.0 M in THF) was purchased from Sigma-Aldrich 
and used as received. Cyclohexylallene, propylsilane, and d-triethylsilane (97% d-purity) 
were purchased from Sigma-Aldrich and were used as received. 4’-Iodoacetophenone 
and N-iodosuccinimide were purchased from Sigma-Aldrich and used as received. 1H and 
13C NMR spectra were obtained in CDCl3 at rt (25 ˚C), unless otherwise noted, on a 
Varian Mercury 400 MHz instrument, Varian Unity 500 MHz instrument, or Varian 
Unity 700 MHz instrument. Chemical shifts of 1H NMR spectra were recorded in parts 
per million (ppm) on the δ scale from an internal standard of residual chloroform (7.24 
ppm). Chemical shifts of 13C NMR spectra were recorded in ppm from the central peak of 
CDCl3 (77.0 ppm) on the δ scale. High-resolution mass spectra (HRMS) were obtained 
on a VG-70-250-s spectrometer manufactured by Micromass Corp. (Manchester UK) at 
the University of Michigan Mass Spectrometry Laboratory. Regioisomeric ratios were 
determined on crude reaction mixtures using NMR or GC. GC analyses were carried out 
on an HP 6980 Series GC System with HP-5MS column (30 m x 0.252 mm x 0.25 µm). 
When noted, a Biotage purification system (model # SP1) was utilized with SNAP (10 g) 
silica columns. Reported regioselectivities were determined by GCMS analysis and 
confirmed by 1H NMR analysis by comparing the ratios of detectable alkenyl protons of 
the major and minor regioisomers in the crude reaction mixture. In cases where >98:2 
regio- or stereoselectivity is reported, minor isomers were not detected by either GCMS 
or NMR based methods. 
 
General Procedure I for the Ni(COD)2/IPr*OMe – promoted hydrosilylation of 1,3-
disubstituted allenes: 
 
THF (1.0 mL) was added to a solid mixture of IPr*OMe 6 (0.05 mmol) and Ni(COD)2 
(0.05 mmol) at rt. After stirring for 10 min at rt the silane (0.5 mmol) was added. The 
reaction mixture was stirred for 10 min at rt followed by the addition of allene (0.5 
mmol) in THF (3.0 mL) over 1 h by syringe pump. The reaction mixture was stirred at rt 
until TLC analysis indicated disappearance of the allene. The reaction mixture was 
filtered through silica gel eluting with 50% v/v EtOAc/hexanes. The solvent was 
removed in vacuo, and the crude residue was purified via flash column chromatography 
on silica gel to afford the desired product. 
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The alkene configuration of representative alkenylsilanes was determined by 1D NOE, 
where alkenyl protons for major isomers were determined to have the following 
observable correlation (confirming Z stereochemistry): 	  
	  	  
General Procedure II for the Pd2dba3/ IPr·HCl – promoted hydrosilylation of 1,3-
disubstituted allenes 
 
THF (1.0 mL) was added to a solid mixture of IPr·HCl 5 (0.025 mmol), t-BuOK (0.025 
mmol), and Pd2dba3 (0.0125 mmol) at rt. After stirring for 10 min at rt, the reaction 
mixture turned dark red and the silane (0.5 mmol) was added. The reaction mixture was 
stirred for 10 min at rt followed by addition of the allene (0.5 mmol) neat by syringe. The 
reaction mixture was stirred at rt for 2 h. The reaction mixture was filtered through silica 
gel eluting with 50% v/v EtOAc/hexanes. The solvent was removed in vacuo, and the 
crude residue was purified via flash column chromatography on silica gel to afford the 
desired product. Product stereochemistry is confirmed via determination of 3J(H-H) 
coupling across the alkene. 	  	  
General procedure III for the Ni(COD)2/DP-IPr-promoted hydrosilylation of 
monosubstituted allenes affording alkenylsilane authentic standards: 
 
THF (1.0 mL) was added to a solid mixture of DP-IPr·HBF4  (0.03 mmol), t-BuOK (0.03 
mmol), and Ni(COD)2 (0.03 mmol) at rt. After stirring for 10 min at rt, the silane (0.3 
mmol) was added. The reaction mixture was stirred for 10 min at rt followed by the 
addition of allene (0.3 mmol) in THF (4.0 mL) over 2 h by syringe pump. The reaction 
mixture was stirred at rt until TLC analysis indicated disappearance of the allene. The 
reaction mixture was filtered through silica gel eluting with 50% v/v EtOAc/hexanes. The 
solvent was removed in vacuo, and the crude residue was purified via flash column 
chromatography on silica gel to afford the desired product. 
 
General procedure IV for the Pd2dba3/ IMes –promoted hydrosilylation of 
monosubstituted allenes affording allylsilane authentic standards: 
 
THF (1.0 mL) was added to a solid mixture of IMes·HCl 4 (0.03 mmol), KO-t-Bu (0.03 
mmol), and Pd2dba3 (0.015 mmol) at rt. After stirring for 10 min at rt, the reaction 
mixture turned bright red and triethylsilane (0.3 mmol) was added. The reaction mixture 
was stirred for 10 min at rt followed by dilution with THF (4.0 mL) and addition of the 
allene (0.3 mmol) neat by syringe. The reaction mixture was stirred at rt for 2 h. The 
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reaction mixture was filtered through silica gel eluting with 50% v/v EtOAc/hexanes. The 
solvent was removed in vacuo, and the crude residue was purified via flash column 
chromatography on silica gel to afford the desired product. 
 
General procedure V for the Ni(COD)2/DP-IPr-promoted hydrosilylation crossover 
experiment:  
 
THF (1.0 mL) was added to a solid mixture of DP-IPr·HBF4  (0.03 mmol), KO-t-Bu (0.03 
mmol) and Ni(COD)2 (0.03 mmol) at rt. After stirring for 10 min at rt, the Et3SiD (0.3 
mmol) and n-Pr3SiH (0.3 mmol) and cyclohexylallene (0.3 mmol) were added in THF 
(4.0 mL) over 2 h by syringe pump. The reaction mixture was filtered through silica gel 
eluting with 50% v/v EtOAc/hexanes. The solvent was removed in vacuo, and the crude 
residue was directly analyzed by GCMS and GCFID. 
 
General procedure VI for the Pd2dba3/ IMes –promoted hydrosilylation crossover 
experiment: 
 
THF (1.0 mL) was added to a solid mixture of IMes·HCl 4 (0.03 mmol), and Pd2dba3 
(0.015 mmol) at rt. Then n-BuLi (0.0.3 mmol) was slowly added to the stirring solution. 
After stirring for 10 min at rt, the Et3SiD (0.3 mmol) and n-Pr3SiH (0.3 mmol) addition of 
cyclohexylallene (0.3 mmol) in THF (4.0 mL) over 2 h by syringe pump. The reaction 
mixture was filtered through silica gel eluting with 50% v/v EtOAc/hexanes. The solvent 
was removed in vacuo, and the crude residue was directly analyzed by GCMS and 
GCFID. 
 
(E)-Benzyldimethyl(pentadec-8-en-7-yl)silane (2a) ( Table 2, Entry 1) 
 
 
 
General procedure II was followed with Pd2dba3 (11.4 mg, 0.0125 mmol), IPr·HCl salt 5 
(10.6 mg, 0.025 mmol), t-BuOK (2.8 mg, 0.025 mmol), benzyldimethylsilane (79 µL, 0.5 
mmol), and pentadeca-1,7-diene (104 mg, 0.5 mmol). The crude residue was purified by 
flash chromatography (100% hexanes) affording a clear oil (135 mg, 75 % yield) (in 
>98:2 regiosel, >98:2 d.r.). 1H NMR (400 MHz, CDCl3): 7.19 (t, J = 7.6 Hz, 2H), 7.04 (t, 
J = 6.8 Hz, 1H), 6.98 (t, J = 7.6 Hz, 2H), 5.22 (dt, J = 15.5, 6.8 Hz, 1H), 5.14 (dd, J = 
15.5, 8.8 Hz, 1H), 2.07 (s, 2H), 1.98 (q, J = 7.0 Hz, 2H), 1.36 – 1.48 (m, 3H), 1.14 – 1.34 
(m, 17H), 0.87 (t, J = 6.6 Hz, 6H), -0.10 (s, 3H), -0.11 (s, 3H); 13C NMR (100 MHz, 
CDCl3): δ 140.5, 131.0, 129.0, 128.2, 128.1, 123.8, 32.9, 31.9, 31.8, 31.7, 30.0, 29.2, 
29.2, 28.9, 28.7, 23.9, 22.7, 14.1, -5.10, -5.15; IR (thin film): ν 2954.8, 2924.4, 2856.0, 
1703.5, 1600.0, 1493, 1452, 1057, 827.8, 697.7 cm-1; HRMS (EI+) (m/z): [M]+ calc for 
C24H42Si, 358.3056; found, 358.3068. 
 
 
 
n-Hex
SiMe2Bn
n-Hex
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(E)-Dimethyl(pentadec-8-en-7-yl)(phenyl)silane (2b) (Table 2, Entry 2) 
 
 
 
General procedure II was followed with Pd2dba3 (11.4 mg, 0.0125 mmol), IPr·HCl salt 5 
(10.6 mg, 0.025 mmol), t-BuOK (2.8 mg, 0.025 mmol), dimethylphenylsilane (77 µL, 0.5 
mmol), and pentadeca-1,7-diene (104 mg, 0.5 mmol). The crude residue was purified by 
flash chromatography (100% hexanes) affording a clear oil (151 mg, 84 % yield) (in 
>98:2 regiosel., >98:2 d.r.). 1H NMR (500 MHz, CDCl3): δ 7.46 (m, 2H), 7.32 (m, 3H), 
5.17 (dt, J = 15.9, 6.2 Hz, 1H), 5.11 (dd, J = 15.9, 6.2 Hz, 1H), 1.95 (q, J = 6.5 Hz, 2H), 
1.60 (t, J = 11.7 Hz, 1H), 1.10 – 1.39 (m, 21H), 0.87 (t, J = 6.8 Hz, 3H), 0.83 (t, J = 6.8 
Hz, 3H), 0.22 (s, 3H), 0.21 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 138.4, 134.1, 130.9, 
129.0, 128.7, 127.5, 32.9, 32.4, 31.83, 31.80, 30.0, 29.2, 29.0, 28.9, 28.8, 22.70, 22.68, 
14.12, 14.10, -4.25, -5.10; IR (thin film): ν 2954.0, 2925.1, 2857, 1709.7, 1465.4, 1427.5, 
1249.4, 1117.7, 829.3, 698.2 cm-1; HRMS (EI+) (m/z): [M]+ calc for C23H40Si, 344.2899; 
found, 344.2907. 
 
(E)-(1,3-Dicyclohexylallyl)dimethyl(phenyl)silane. (2c) (Table 2, Entry 3) 
 
 
 
General procedure II was followed with Pd2dba3 (13.7 mg, 0.015 mmol), IPr·HCl salt 5 
(12.8 mg, 0.03 mmol), t-BuOK (3.6 mg, 0.03 mmol), dimethylphenylsilane (46 µL, 0.3 
mmol), and 1,3-dicyclohexylpropa-1,2-diene (61 mg, 0.3 mmol). The crude residue was 
purified by flash chromatography (100% hexanes) affording a clear oil (98.7 mg, 58 % 
yield) (in >98:2 regiosel., >98:2 d.r.). 1H NMR (400 MHz, CDCl3): δ 7.54 – 7.46 (m, 2H), 
7.37 – 7.29 (m, 3H), 5.31 – 5.21 (m, 1H), 5.13 (dd, J = 15.2, 6.7 Hz, 1H), 1.93 (m, J = 
10.6, 7.0 Hz, 1H), 1.76 – 1.56 (m, 11H), 1.50 – 1.38 (m, 2H), 1.33 – 0.90 (m, 11H), 0.30 
(d, J = 2.0 Hz, 3H), 0.27 (d, J = 2.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 139.43, 
136.25, 133.96, 128.50, 127.43, 125.88, 41.11, 40.14, 38.69, 34.08, 33.64, 33.48, 31.48, 
26.77, 26.74, 26.32, 26.26, 26.14, -2.64, -3.37; IR (thin film): ν 2917.9, 2847.5, 1446.9, 
1426.0, 1245.3, 1109.7, 997.9, 966.1, 891.9, 851.1, 811.4, 767.3, 732.3, 697.5, 641.7 cm-
1; HRMS (EI+) (m/z): [M+] calc for C23H36Si, 340.2586; found, 340.2589. 
 
(E)-8-(dimethyl(phenyl)silyl)-2,2,3,3,11,11,12,12-octamethyl-4,10-dioxa-3,11-
disilatridec-6-ene (2d) (Table 2, Entry 4) 
 
 
 
General procedure II was followed with Pd2dba3 (4.8 mg, 0.0052 mmol), IPr·HCl salt 5 
(4.5 mg, 0.0105 mmol), t-BuOK (1.2 mg, 0.0105 mmol), dimethylphenylsilane (32 µL, 
0.21 mmol), and 2,2,3,3,11,11,12,12-octamethyl-4,10-dioxa-3,11-disilatrideca-6,7-diene 
n-Hex
SiMe2Ph
n-Hex
Cy
SiMe2Ph
Cy
SiMe2Ph
TBSO OTBS
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(70 mg, 0.21 mmol). The crude residue was purified by flash chromatography (10% 
EtOAc:hexanes) affording a clear oil (60 mg, 64 % yield). 1H NMR (500 MHz, CDCl3): 
δ 7.52 (m, 2H), 7.35 (m, 3H), 5.63 (dd, J = 15.0, 9.0 Hz, 1H), 5.40 (dt, J = 15.0, 6.1 Hz, 
1H), 4.12 (d, J = 5.8 Hz, 2H), 3.73 (m, 2H), 2.00 (m, 1H), 0.912 (s, 9H), 0.872 (s, 9H), 
0.322 (s, 3H), 0.309 (s, 3H),0.063 (s, 6H), -0.0047 (s, 3H), -0.014 (s, 3H); 13C NMR (125 
MHz, CDCl3): δ 134.0, 133.0, 130.0, 128.8, 128.4, 127.5, 64.2, 63.9, 36.6, 26.0, 18.3,  
-3.7, -4.0, -5.11, -5.14, -5.40, -5.43; IR (thin film): ν 2953.5, 2926.2, 1704.1, 1462.4, 
1250.7, 1089.8, 831.8 cm-1; HRMS (ESI+) (m/z): [M+Na]+ calc for C25H48O2Si3, 
487.2854; found, 487, 2851. 
 
(Z)-Benzyldimethyl(tetradec-7-en-7-yl)silane (3a) (Table 2, Entry 5) 
 
 
 
General procedure I was followed with Ni(COD)2 (13.8 mg,  0.05 mmol), IPr*OMe 6 
(47.2 mg, 0.05 mmol), benzyldimethylsilane (79 µL,  0.5 mmol), and pentadeca-1,7-
diene (104 mg, 0.5 mmol). The crude residue was purified by flash chromatography 
(100% hexanes) affording a clear oil (159 mg, 89% yield) (in >98:2 regiosel.; >98:2 d.r.). 
1H NMR (400 MHz, CDCl3): δ 7.19 (t, J = 7.8 Hz, 2H), 7.05 (m, 1H), 7.00 (m, 2H), 5.97 
(t, J = 7.2 Hz, 1H), 2.20 (s, 2H), 2.01 – 2.08 (m, 2H), 1.93 – 1.99 (m, 3H), 1.15 – 1.36 (m, 
18H), 0.88 (m, 6H), 0.080 (s, 6H); 13C NMR (100 MHz, CDCl3): δ 144.0, 140.3, 137.4, 
128.32, 128.27, 128.0, 123.9, 38.4, 32.3, 31.9, 31.8, 30.0, 29.4, 29.2, 29.1, 28.5, 26.7, 
22.7, 22.6, 14.1, -1.7; IR (thin film): ν 2953.5, 2923.7, 2853.6, 1716.2, 1600.8, 1493.2, 
1452.2, 1377.5, 1248.7, 1056.5, 826.3 cm-1; HRMS (EI+) (m/z): [M+] calc for C24H42Si, 
358.3056; found, 358.3066. 
 
(Z)-Dimethyl(phenyl)(tetradec-7-en-7-yl)silane (3b) (Table 2, Entry 6) 
 
 
 
General procedure I was followed with Ni(COD)2 (13.8 mg, 0.05 mmol), IPr*OMe 6 
(47.2 mg, 0.05 mmol), dimethylphenylsilane (77 µL,  0.5 mmol), and pentadeca-1,7-
diene (104 mg, 0.5 mmol). The crude residue was purified by flash chromatography 
(100% hexanes) affording a clear oil (147 mg, 85 % yield) (in >98:2 regosel, >98:2 d.r.). 
1H NMR (400 MHz, CDCl3): δ 7.52 (m, 2H), 7.33 (m, 3H), 6.04 (t, J = 7.2 Hz, 2H), 1.08-
1.36 (m, 18H), 0.87 (t, J = 8.0 Hz, 3H), 0.83 (t, J = 8.0 Hz, 3H), 0.369 (s, 6H); 13C NMR 
(100 MHz, CDCl3): δ 144.8, 140.2, 136.9, 133.8, 128.6, 127.6, 38.6, 32.5, 31.9, 31.7, 
31.0, 29.8, 29.4, 29.2, 28.9, 22.7, 22.6, 14.12, 14.06, -0.83; IR (thin film): 2954.0, 2923.6, 
2855.0, 1708.5, 1610.1, 1465.0, 1427.5, 1248.5, 1110.7, 831.2 cm-1; HRMS (EI+) (m/z): 
[M-CH3]+ calc for C22H37Si, 329.2665; found, 329.2669. 
 
 
 
 
SiMe2Bn
n-Hex n-Hex
SiMe2Ph
n-Hex n-Hex
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(Z)-(1,3-Dicyclohexylprop-1-en-2-yl)dimethyl(phenyl)silane (3c) (Table 2, Entry 7) 
 
 
 
General procedure I was followed with Ni(COD)2 (13.8 mg, 0.05 mmol), IPr*OMe 6 
(47.2 mg,  0.05 mmol), dimethylphenylsilane (77 µL, 0.5 mmol), and  1,3-
dicyclohexylpropa-1,2-diene (102 mg, 0.5 mmol). The crude residue was purified by 
flash chromatography (100% hexanes) affording a clear oil (110.7 mg, 65%) (in >98:2 
regiosel., 96:4 d.r.). 1H NMR (500 MHz, CDCl3): δ 7.50 - 7.57 (m, 2H), 7.30 – 7.36 (m, 
3H), 5.75 (d, J = 10.4 Hz, 1H), 5.70 (d, J = 10.4 Hz, 0.06H, minor E-isomer), 1.99 - 2.05  
(m, 1H), 1.97 (dd, J = 6.8, 0.6 Hz, 2H), 1.63 – 1.71 (m, 5H), 1.50 – 1.60 (m, 4H), 1.41 – 
1.36 (m, 2H), 1.11 – 1.22 (m, 4H), 0.91 – 1.01 (m, 4H), 0.74 – 0.84 (m, 2H), 0.38 (s, 6H); 
13C NMR (100 MHz, CDCl3): δ 151.72, 140.51, 133.70, 132.89, 128.48, 127.50, 46.62, 
41.24, 37.65, 33.11, 32.95, 26.77, 26.49, 25.92, 25.65, -0.81; IR (thin film): ν 2918.4, 
2846.8, 1609.5, 1446.8, 1426.3, 1245.8, 1108.6, 903.4, 830.3, 812.1, 768.4, 727.2, 698.0, 
675.0 cm-1; HRMS (EI+) (m/z): [M+] calc for C23H36Si, 340.2586; found, 340.2585. 
 
(Z)-7-(benzyldimethylsilyl)-2,2,3,3,11,11,12,12-octamethyl-4,10-dioxa-3,11-
disilatridec-6-ene (3d) (Table 2, Entry 8) 
 
 
 
General procedure I was followed with Ni(COD)2 (2.9 mg, 0.00105 mmol), IPr*OMe 6 
(9.8 mg, 0.00105 mmol), benzyldimethylsilane (33 µL, 0.21 mmol), and 
2,2,3,3,11,11,12,12-octamethyl-4,10-dioxa-3,11-disilatrideca-6,7-diene (70 mg, 0.21 
mmol). The crude residue was purified by flash column chromatography (10% EtOAc: 
hexanes) affording a clear oil (75 mg, 75 % yield) (in >98:2 regiosel., 85:15 d.r.). 1H 
NMR (500 MHz): δ 7.18 (t, J = 9.0 Hz, 2H), 7.05 (t, J = 9.0 Hz, 1H), 6.97 (d, J = 9.0 Hz, 
2H), 6.13 (t, J = 7.4, 1 H, major isomer), 5.90 (t, J  = 7.4 Hz, 0.1H, minor E-isomer), 4.04 
(d, J = 9.4 Hz, 2H), 3.42 (t, J = 8.5 Hz, 2H), 2.23 (t, J = 7.4 Hz, 2H),  2.16 (s, 2H), 0.88 (s, 
10H), 0.86 (s, 10H), 0.098 (s, 6H), 0.035 (s, 6H), 0.0093 (s, 6H); 13C NMR (125 MHz, 
CDCl3): δ 145.4, 143.9 (minor), 139.6, 139.4 (minor),135.3, 128.3, 128.1, 124.2, 124.0  
(minor),63.9, 62.7, 40.9, 26.5, 26.02, 26.00, 18.4, -0.09, -1.9, -5.1, -5.2; IR (thin film): 
ν 2953.5, 2926.2, 2856.6, 1704.1, 1601.0, 1462.4, 1250.7, 1089.8, 831.8, 697.8 cm-1; 
HRMS (ESI+) (m/z): [M+Na]+ calc for C26H50S3O2, 501.3011; found, 501.3009.  
 
(Z)-Benzyl(cyclopentadec-1-en-1-yl)dimethylsilane (8) (Scheme 1) 
 
 
SiMe2Ph
Cy Cy
SiMe2Bn
TBSO OTBS
SiMe2Bn
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General procedure I was followed with Ni(COD)2 (6.6 mg, 0.024 mmol), IPr*OMe 6 
(22.7 mg, 0.024 mmol), benzyldimethylsilane (37.9 µL, 0.24 mmol), and cyclopentadeca-
1,2-diene (50 mg, 0.24 mmol). The crude residue was purified by flash chromatography 
(100% hexanes) affording a clear oil (61 mg, 71% yield) (in >98:2 regiosel., >98:2 d.r.). 
1H NMR (500 MHz, CDCl3): δ 7.18 (t, J = 9.9 Hz, 2H), 7.04 (t, J = 9.9 Hz, 1H), 7.00 (d, 
J = 9.9 Hz, 2H), 5.94 (t, J = 8.6 Hz, 1H), 2.21 (s, 2H), 2.17 (m, 2H), 2.07 (m, 2H), 1.39 – 
1.47 (m, 2H), 1.16 – 1.38 (m, 20H), 0.069 (s, 6H); 13C NMR (175 MHz, CDCl3): 145.2, 
140.3, 137.3, 128.3, 128.0, 123.9, 37.6, 31.2, 29.4, 29.0, 27.7, 27.6, 27.25, 27.20, 27.1, 
26.9, 26.8, 26.7, 26.5, 26.0, -1.7; IR (thin film): ν 2925.9, 2855.4, 1493.2, 1451.4, 1248.6, 
1151.4, 828.7 cm-1; HRMS (EI+) (m/z): [M]+ calc for C24H40Si, 356.2899; found, 
356.2901. 
 
(E)-Benzyl(cyclopentadec-2-en-1-yl)dimethylsilane (9) (Scheme 1) 
 
 
 
General procedure II was followed with Pd2dba3 (5.5 mg, 0.006 mmol), IPr·HCl salt 5 
(5.1 mg, 0.012 mmol), t-BuOK (1.3 mg, 0.012 mmol), benzyldimethylsilane (37.9 µL, 
0.24 mmol), and cyclopentadeca-1,2-diene (50 mg, 0.24 mmol). The crude residue was 
purified by flash chromatography (100% hexanes) affording a clear oil (57 mg, 66 % 
yield) (in >98:2 regiosel., >98:2 d.r.). 1H NMR (700 MHz, CDCl3): δ 7.19 (t, J = 7.5 Hz, 
2H), 7.05 (t, J = 7.5 Hz, 1H), 6.98 (d, J = 7.5, 2H), 5.15 (m, 2H), 2.15 (m, 1H), 2.07 (s, 
2H), 1.96 (m, 1H), 1.09 – 1.5 (m, 26H), -0.103 (s, 3H), -0.118 (s, 3H). 1H NMR (700 
MHz, C6D6): 7.21 (m, 2H (overlapping signals)), 7.03-7.10 (m, 3H), 5.20 (dd, J = 15.8, 
10.2 Hz, 1H), 5.15 (ddd, J = 15.8, 10.2, 4.0 Hz, 1H), 2.21 (m, 1H), 2.10 (s, 2H), 2.04 (m, 
1H), 1.25 – 1.52 (m, 26H), -0.0039 (s, 6H); 13C NMR (175 MHz, CDCl3): δ 140.5, 131.7, 
129.1, 128.2, 128.1, 123.8, 31.9, 31.5, 29.0, 28.7, 28.2, 27.2, 27.1, 26.9, 26.8, 26.7, 25.4, 
23.8, -5.2, -5.3; IR (thin film): ν 2926.0, 2856.4, 1599.8, 1451.8, 1257.8, 1152.4, 826.8 
cm-1; HRMS (EI+) (m/z): [M]+ calc for C24H40Si, 356.2899; found, 356.2902. 
 
(E)-(1-Cyclohexylnon-2-en-1-yl)dimethyl(phenyl)silane and (E)-(1-cyclohexylnon-1-
en-3-yl)dimethyl(phenyl)silane (10a & 11a) (Scheme 2) 
 
 
 
General procedure II was followed with Pd2dba3 (22.9 mg, 0.025 mmol), IPr·HCl salt 5 
(21.3 mg, 0.05 mmol), t-BuOK (5.6 mg, 0.05 mmol), dimethylphenylsilane (77 µL, 0.5 
mmol), and nona-1,2-dien-1-ylcyclohexane (103.2 mg, 0.5 mmol). The crude residue was 
purified by flash chromatography (100% hexanes) affording a clear oil (137 mg, 80 % 
SiMe2Bn
4
Cy
SiMe2Ph
n-Hex Cy n-Hex
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yield) (in 60:40 regiosel. 10a & 11a). 1H NMR (500 MHz, CDCl3): δ 7.53 (m, 4 H), 7.37 
(m, 6H), 5.33 (dd, J = 15.7, 10.8 Hz, 1H), 5.21 (dt, J = 16, 11 Hz, 1H), 5.19 (dd, J = 16, 
11 Hz, 0.7 Hz), 5.14 (dd, J = 16, 9.2 Hz, 0.7H), 2.02 (m, 2H), 1.94 (m, 1H), 1.57 – 1.76 
(m, 11H), 1.10 – 1.38 (m, 26H), 0.936 (t, J = 10 Hz, 3H), 0.90 (t, J = 10 Hz, 3H), 0.33 (s, 
3H), 0.30 (s, 3H), 0.29 (2H), 0.278 (s, 2H); 13C NMR (125 MHz, CDCl3): δ 139.5, 138.4, 
135.1, 134.2, 134.0, 130.3, 128.7, 128.60, 128.55, 128.2, 127.5, 41.1, 40.3, 38.8, 34.2, 
33.7, 33.6, 32.9, 32.4, 31.9, 31.8, 31.5, 30.0, 29.10, 29.06, 28.9, 28.8, 26.82, 26.80, 26.4, 
26.2, 22.74, 22.71, 14.2, 14.1, -2.6, -3.3, -4.3, -5.1; IR (thin film); ν 2925.4, 2852.1, 
1725.7, 1448.5, 1427.5, 1249.4, 1117.9, 1061.8, 971.7, 828.9, 698.7, 418.6 cm-1; HRMS 
(EI+) (m/z): [M]+ calc for C23H38Si, 342.2743; found, 342.2749. 
 
(Z)-Benzyldimethyl(2-methyldodec-5-en-5-yl)silane and (Z)-benzyldimethyl(2-
methyldodec-4-en-5-yl)silane (12a & 13a) (Table 3, Entry 1) 
 
 
 
General procedure I was followed with Ni(COD)2 (13.8 mg, 0.05 mmol), IPr*OMe 6 
(47.2 mg, 0.05 mmol), benzyldimethylsilane (79 µL, 0.5 mmol), and 2-methyldodeca-
14,5-diene (90.2 mg, 0.5 mmol). The crude residue was purified by flash chromatography 
(100% hexanes) affording a clear oil (114 mg, 69% yield) (in 50:50 rr, of 12a:13a, 91:9 
allyl:vinyl regiosel). 1H NMR (400 MHz, CDCl3): δ 7.21 (t, J = 8.0 Hz, 4H), 7.07 (t, J = 
8.0 Hz, 2H), 7.01 (d, J = 7.1 Hz, 4H), 6.02 (t, J = 8.0 Hz, 1H), 5.99 (t, J = 8.0 Hz, 1H), 
5.09 (m, 0.19H (minor allyl isomer)), 2.22 (s, 4H), 2.13 (m, 1H), 1.94 -2.09 (m, 9H), 1.61 
(m, 1H), 1.48 (m, 2H), 1.20 – 1.39 (m, 25H), 1.05 – 1.12 (m, 2H), 0.88 – 0.94 (m, 15H), 
0.87 (s, 4H), 0.85 (s, 3H), 0.10 (s, 4H), 0.097 (s, 4H), 0.07 (s, 2H); 13C NMR (100 MHz, 
CDCl3, major signals from the 3 isomers are listed): δ 146.2, 143.9, 142.9 140.4, 140.29, 
140.27, 139.7, 134.9, 128.3, 128.0, 125.1, 123.9, 123.8, 45.3, 41.1, 40.5, 38.6, 37.2, 36.3, 
32.3, 31.9, 31.8, 31.02, 30.1, 29.6, 29.4, 29.2, 29.1, 29.0, 28.3, 27.9, 26.8, 26.7, 26.5, 
22.64, 22.60, 22.46, 14.1, -1.64, -1.7, -1.9; IR (thin film): ν 2952.9, 2924.8, 1600.8, 
1493.1, 1465.3, 1248.1, 1205.2, 1153.5, 1055.9 826.1 cm-1; HRMS (EI+) (m/z): [M]+ calc 
for C22H38Si, 330.2743; found, 330.2739. 
 
(Z)-Benzyldimethyl(2-methylundec-4-en-4-yl)silane (12b) (Table 3, Entry 2). 
 
 
 
General procedure I was followed with Ni(COD)2 (13.8 mg, 0.05 mmol), IPr*OMe 6 
(47.2 mg, 0.05 mmol), benzyldimethylsilane (79 µL, 0.5 mmol), and 2-methylundeca-
3,4-diene (83.2 mg, 0.5 mmol). The crude residue was purified by flash chromatography 
(100% hexanes) affording a clear oil (101.3 mg, 64%) (in 98:2 regiosel., >98:2 d.r.). 1H 
NMR (500 MHz, CDCl3): δ 7.27 – 7.22 (m, 2H), 7.11 (t, J = 7.4 Hz, 1H), 7.08 – 7.05 (m, 
2H), 5.99 (t, J = 7.5 Hz, 1H), 2.27 (s, 2H), 2.15 (q, J = 7.3 Hz, 2H), 1.94 (d, J = 6.9 Hz, 
2H), 1.55 – 1.45 (m, 1H), 1.43 – 1.30 (m, 8H), 0.95 (t, J = 7.0 Hz, 3H), 0.88 (d, J = 6.6 
Hz, 6H), 0.14 (s, J = 12.2 Hz, 6H); 13C NMR (125 MHz, CDCl3): δ 145.62, 140.29, 
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136.17, 128.29, 128.07, 123.96, 48.37, 32.48, 31.88, 30.17, 29.21, 28.18, 26.77, 22.69, 
22.34, 14.12, -1.70. IR (cm-1): ν 2951.5, 2921.7, 2851.0, 1601.2, 1492.6, 1461.3, 1451.2, 
1363.5, 1247.3, 1204.7, 1153.3, 1055.9, 901.0, 825.2, 789.5, 759.3, 696.5 cm-1; HRMS 
(EI+) (m/z): [M+] calc for C21H36Si, 316.2586; found, 316.2590. 
 
(Z)-(1-Cyclohexylnon-2-en-2-yl)dimethyl(phenyl)silane (12c) (Table 3, Entry 3) 
 
 
 
General procedure I was followed with Ni(COD)2 (13.8 mg, 0.05 mmol), IPr*OMe 6 
(47.2 mg, 0.05 mmol), dimethylphenylsilane (77 µL, 0.5 mmol), and nona-1,2-dien-1-
ylcyclohexane (103 mg, 0.5 mmol). The crude residue was purified by flash 
chromatography (100% hexanes) affording a clear oil (87.3 mg, 51%) (in >98:2 regiosel, 
>98:2 d.r.). 1H NMR (500 MHz, CDCl3): δ 7.57 – 7.52 (m, 2H), 7.37 – 7.32 (m, 3H), 
6.00 (t, J = 7.5 Hz, 1H), 2.01 (d, J = 6.8 Hz, 2H), 1.96 (q, J = 7.4 Hz, 2H), 1.74 – 1.67 (m, 
4H), 1.67 – 1.62 (m, 1H), 1.28 – 1.11 (m, 12H), 0.93 – 0.77 (m, 2H), 0.86 (t, J = 7.3 Hz, 
3H), 0.40 (s, 6H); 13C NMR (125 MHz, CDCl3): δ 146.12, 140.23, 134.89, 133.73, 
128.52, 127.58, 46.90, 37.72, 33.19, 32.54, 31.70, 29.81, 28.96, 26.75, 26.47, 22.58, 
14.05, -0.84; IR (thin film): ν 2918.3, 2848.9, 1609.0, 1447.8, 1426.7, 1246.4, 1109.0, 
831.0, 812.4, 769.2, 726.6, 698.3, 669.5 cm-1; HRMS (EI+) (m/z): [M+] calc for C23H38Si, 
342.2743; found 342.2740. 
 
(Z)-Benzyl(1-cyclohexylnon-2-en-2-yl)dimethylsilane (12d) (Table 3, Entry 4) 
 
 
 
General procedure I was followed with Ni(COD)2 (13.8 mg, 0.05 mmol), IPr*OMe 6 
(47.2 mg, 0.05 mmol), benzyldimethylsilane (79 µL, 0.5 mmol), and nona-1,2-dien-
1ylcyclohexane (103 mg, 0.5 mmol). The crude residue was purified by flash 
chromatography (100% hexanes) affording a clear oil (125 mg, 70 %) (in >98:2 regiosel., 
>98:2 d.r.). 1H NMR (500 MHz, CDCl3): δ 7.25 – 7.19 (m, 2H), 7.09 (t, J = 7.4 Hz, 1H), 
7.05 – 7.01 (m, 2H), 5.93 (t, J = 7.5 Hz, 1H), 2.23 (s, 2H), 2.11 (q, J = 7.4 Hz, 2H), 1.90 
(d, J = 6.8 Hz, 2H), 1.73 – 1.63 (m, 5H), 1.41 – 1.27 (m, 8H), 1.21 – 1.12 (m, 3H), 1.11 – 
1.04 (m, 1H), 0.92 (t, J = 7.0 Hz, 3H), 0.86 – 0.74 (m, 2H), 0.10 (s, J = 2.7 Hz, 6H); 13C 
NMR (125 MHz, CDCl3): δ 145.51, 140.29, 135.36, 128.24, 128.05, 123.92, 46.79, 37.67, 
33.21, 32.43, 31.82, 30.14, 29.18, 26.76, 26.74, 26.47, 22.66, 14.09, -1.70; IR (thin film): 
ν 2918.5, 2849.2, 1600.9, 1492.4, 1448.8, 1246.7, 1205.0, 1153.4, 1055.7, 900.8, 826.8, 
789.5, 759.1, 696.3 cm-1; HRMS (EI+) (m/z): [M+] calc for C24H40Si, 356.2899; found, 
356.2894. 
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(Z)-Benzyl(2,2-dimethylundec-4-en-4-yl)dimethylsilane (12e) (Table 3, Entry 5)  
 
 
 
General procedure I was followed with Ni(COD)2 (13.8 mg, 0.05 mmol), IPr*OMe 6 
(47.2 mg, 0.05 mmol), benzyldimethylsilane (79 µL, 0.5 mmol), and 2,2-
dimethylundeca-3,4-diene (90.2 mg, 0.5 mmol). The crude residue was purified by flash 
chromatography (100% hexanes) affording a clear oil (86.0 mg, 52%) (in >98:2 regiosel., 
>98:2 d.r.). 1H NMR (500 MHz, CDCl3): δ 7.22 (t, J = 7.6 Hz, 2H), 7.08 (t, J = 7.4 Hz, 
1H), 7.05 – 7.01 (m, 2H), 6.05 (t, J = 7.6 Hz, 1H), 2.26 (s, 2H), 2.17 (d, J = 7.6 Hz, 2H), 
1.97 (s, 2H), 1.45 – 1.38 (m, 2H), 1.37 – 1.28 (m, 6H), 0.92 (t, J = 7.0 Hz, 3H), 0.87 (s, 
9H), 0.10 (s, J = 4.4 Hz, 6H); 13C NMR (126 MHz, CDCl3): δ 148.74, 140.56, 134.38, 
128.32, 128.05, 123.90, 49.36, 32.99, 32.04, 31.85, 30.14, 29.87, 29.25, 26.90, 22.66, 
14.11, -1.18. IR (cm-1):  ν 2949.6, 2853.0, 1600.2, 1492.4, 1451.1, 1361.0, 1247.7, 
1203.8, 1153.8, 1056.5, 826.5, 790.3, 759.8, 696.5; HRMS (EI+) (m/z): [M+] calc for 
C22H38Si [M-H]+ 315.2508, found 315.2508. 
 
(Z)-Benzyl(1-cyclohexyl-5-phenylpent-2-en-2-yl)dimethylsilane (12f) (Table 3, Entry 
6) 
 
 
General procedure I was followed with Ni(COD)2 (13.8 mg, mmol), IPr*OMe 6 (16.3 mg, 
0.03 mmol), benzyldimethylsilanesilane (79 µL, 0.5 mmol), and (5-cyclohexylpenta-3,4-
dien-1-yl)benzene (113 mg, 0.5 mmol). The crude residue was purified by flash 
chromatography (100% hexanes) affording a clear oil (141 mg, 71 % yield) (in 95:5 d.r., 
>98:2 regiosel.). 1H NMR (400 MHz, CDCl3): δ 7.27 (m, 2H), 7.16 (m, 4H), 7.04 (m, 
1H), 6.95 (m, 3H), 5.93 (t, J = 7.3 Hz, 1H), 5.80 (t, J = 7.3 Hz, 0.05H), 2.65 (t, J = 8.0 Hz, 
2H), 2.40 (q, J = 8.0 Hz, 2H), 2.15 (s, 2H), 2.04 (s, 2H), 1.86 (d, J = 7.1 Hz, 2H), 1.56 – 
1.70 (m, 9H), 1.04 – 1.23 (m, 6H), 0.732 (m, 3H), 0.043 (s, 6H); 13C NMR (175 MHz, 
CDCl3): δ 144.0, 141.9, 140.1, 136.5, 128.5, 128.3, 128.2, 128.1, 125.8, 124.0, 46.7, 37.6, 
36.4, 34.3, 33.2, 26.7, 26.6, 26.4, -1.74; IR (thin film): ν 2361.1, 2339.1, 2177.6, 1134.0, 
667.9, 437.8 cm-1; HRMS (EI+) (m/z): [M-Me]+ calc for C25H33Si, 261.2352; found, 
361.2359. 
 
(Z)-Benzyl(4-(benzyloxy)-1-cyclohexylbut-2-en-2-yl)dimethylsilane (12g) (Table 3, 
Entry 7) 
 
 
 
General procedure I was followed with Ni(COD)2 ( 13.8 mg, 0.05 mmol), IPr*OMe 6 
(47.2 mg, 0.05 mmol), benzyldimethylsilane (79 mL, 0.5 mmol), and (((4-
cyclohexylbuta-2,3-dien-1-yl)oxy)methyl)benzene (121 mg, 0.5 mmol). The crude 
residue was purified by flash chromatography (5 % EtOAc: hexanes) affording a clear oil 
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(130 mg, 66 % yield) (in >98:2 regosel., 90:10 d.r.). 1H NMR (400 MHz, CDCl3): 7.32 (d, 
J = 4.5 Hz, 4H), 7.27 (m, 1H), 7.17 (t, J = 7.4 Hz, 2H), 7.05 (t, J = 7.4 Hz, 1H), 6.93 (d, J 
= 7.4 Hz, 2H), 6.09 (t, J = 6.9 Hz, 1H), 4.46 (s, 2H), 3.93 (d, J = 6.9 Hz, 2H), 2.12 (s, 2H), 
1.93 (d, J = 6.5 Hz, 2H), 1.56 – 1.70 (m, 6H), 1.11 (m, 4H), 0.796 (m, 2H), 0.030 (s, 6H); 
13C NMR (100 MHz, CDCl3): δ 140.9, 140.5, 139.7, 138.2, 128.4, 128.3, 128.1, 128.0, 
127.7, 124.1, 72.5, 69.4, 46.6, 37.3, 33.2, 26.6, 26.4, -1.8; IR (thin film): 2920.1, 2849.3, 
1599.7, 1493.4, 1449.7, 1248.7, 1096.0, 1027.8 cm-1; HRMS (APCI) (m/z): [M+H]+ calc 
for C23H36OSi, 393.2608; found, 393.2627. 
 
(1-Cyclohexylallyl-2-d)triethylsilane (14) (Scheme 3) 
	  
	  
	  
General procedure IV was followed with Pd2dba3 (13.7 mg, 0.015 mmol), IMes·HCl salt 
4 (10.2 mg, 0.03 mmol), n-BuLi (12 mL, 0.03 mmol, 2.5 M in hexanes), triethylsilane 
(47.7 µL, 0.3 mmol), and cyclohexylallene (36.6 mg, 0.3 mmol). The crude residue was 
purified by flash chromatography (100% hexanes) affording a clear oil (50 mg, 70 % 
yield) (in >98:2 regiosel.). 1H NMR (700 MHz, CDCl3): δ 4.83 (s, 1H), 4.77 (s, 1H), 1.65 
– 1.74 (m, 3H), 1.44 – 1.63 (m, 2H), 0.986 – 1.27 (m, 6H), 0.93 (t, J = 8.9 Hz, 9H ), 
0.561 (q, J = 8.9 Hz, 6H); 13C NMR (174 MHz, CDCl3): d 112.6, 39.8, 38.3, 34.3, 31.6, 
26.90, 26.89, 26.3, 7.7, 3.3; IR (thin film): n 2922.1, 1259.9, 1088.6, 799.9 cm-1; HRMS 
(EI+) (m/z): [M]+ calc for C15H29DSi, 239.2180; found, 239.2185.  
 
[3-(Triethylsilyl)-2-propen-1-yl]-cyclohexane (15) (Scheme 3) 
	  
	  
	  
General procedure IV was followed with Pd2dba3 (13.7 mg, 0.015 mmol), IMes·HCl salt 
4  (10.2 mg, 0.03 mmol), t-BuOK (3.4 mg, 0.03 mmol), triethylsilane (48 µL, 0.3 mmol), 
and cyclohexylallene (36.6 mg, 0.3 mmol). The crude residue was purified by flash 
chromatography (100% hexanes) affording a clear oil (57 mg, 80% yield) (in >98:2 
regiosel.). Spectral data matched that previously reported.4 
 
(1-Cyclohexylallyl)tripropylsilane (16) (Scheme 3) 
	  
	  
	  
General procedure IV was followed with Pd2dba3 (13.7 mg, 0.015 mmol), IMes·HCl salt 
4 (10.2 mg, 0.03 mmol), t-BuOK (3.4 mg, 0.03 mmol), triethylsilane (48 µL, 0.3 mmol), 
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and cyclohexylallene (36.6 mg, 0.3 mmol). The crude residue was purified by flash 
chromatography (100% hexanes) affording a clear oil (49 mg, 58 56 % yield) (in >98:2 
regiosel.). 1H NMR (700 MHz, CDCl3): 5.69 (dt, J = 17.2, 9.5 Hz, 1H), 4.83 (dd, J =10.5, 
2.7 Hz, 1H), 4.77 (dd, J = 17.2, 2.3 Hz, 1H), 1.66 (m, 3H), 1.58 - 1.60 (m, 1H), 1.50 – 
1.57 (m, 3H), 1.41 – 1.48 (m, 1H), 1.27 – 1.37 (m, 6 H), 1.00 – 1.22 (m, 1H), 0.935 (t, J 
= 8.0 Hz, 9H),  0.513 – 0.569 (m, 6H); 13C NMR (175 MHz, CDCl3): 138.6, 112.8, 40.5, 
38.4, 34.3, 31.6, 26.9, 26.3, 18.8, 17.7 ,15.3; IR (thin film): n  3073.1, 2954.5, 2924.1, 
2867.7, 2661.8, 1623.3, 1450.1, 1331.9, 1203.2, 1067.5, 998.8, 894.7, 740.4 cm-1; HRMS 
(EI+) (m/z): [M]+ calc for C18H36Si, 280.2586; found, 280.2588.  
 
(3-Cyclohexylprop-1-en-2-yl-3-d)triethylsilane (18) (Scheme 3) 
	  
	  
	  
General procedure III was followed with Ni(COD)2 (8.25 mg, 0.03 mmol), DP-IPr·HBF4 
(18.9 mg, 0.03 mmol), n-BuLi (12 mL, 0.03 mmol, 2.5 M in hexanes), d-triethylsilane 
(47.7 µL, 0.3 mmol), and cyclohexylallene (36.6 mg, 0.3 mmol). The crude residue was 
purified by flash chromatography (100% hexanes) affording a clear oil (60 mg, 83 % 
yield) (in >98:2 regiosel.). 1H NMR (700 MHz, CDCl3): d 5.56 (dd, J = 3.3, 1.1 Hz, 1H), 
5.31 (d, J = 3.3 Hz, 1H), 1.94 (d, J = 7 Hz, 1H), 1.64 – 1.72 (m, 5H), 1.11-1.20 (m, 4H), 
0.91 (t, J = 8.0 Hz, 9H), 0.77 – 0.83 (m, 2H), 0.58 (q, J = 8.0 Hz, 6H); 13C NMR (175 
MHz, CDCl3): d 147.3, 126.5, 36.3, 33.43, 33.41, 26.7, 26.4, 7.3, 3.0; IR (thin film): 
n 2922.3, 2874.8, 2850.5, 1447.7, 1415.9, 1348.1, 1261.0 1236.3, 1012.0, 923.5, 892.9 
cm-1; HRMS (EI) (m/z): [M]+ calc for C13H24DSi, 210.1788; found, 210.1789.  
 
[2-(Triethylsilyl)-2-propen-1-yl]-cyclohexane (19) (Scheme 3) 
	  
	  
	  
General procedure III was followed with Ni(COD)2 (8.25 mg, 0.03 mmol), DP-IPr·HBF4  
(18.9 mg, 0.03 mmol), KO-t-Bu (3.4 mg, 0.03 mmol), triethylsilane (48 µL, 0.3 mmol), 
and cyclohexylallene (36.6 mg, 0.3 mmol). The crude residue was purified by flash 
chromatography (100% hexanes) affording a clear oil (60 mg, 84 % yield) (in >98:2 
regiosel.). Spectral data matched that previously reported.4 	  
(3-Cyclohexylprop-1-en-2-yl)tripropylsilane (20) (Scheme 3) 
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General procedure III was followed with Ni(COD)2 (8.25 mg, 0.03 mmol), DP-IPr·HBF4  
(18.9 mg, 0.03 mmol), t-BuOK (3.4 mg, 0.03 mmol), tripropysilane (µL, 0.3 mmol), and 
cyclohexylallene (36.6 mg, 0.3 mmol). The crude residue was purified by flash 
chromatography (100% hexanes) affording a clear oil (47 mg, 56 % yield) (in >98:2 
regiosel.). 1H NMR (700 MHz, CDCl3): d 5.54 (m, 1H), 5.30 (d, J = 3.4 Hz, 1H), 1.96 (d, 
J = 5.9 Hz, 2H), 1.60-1.71 (m, 6H), 1.25-1.32 (m, 6H), 1.10-1.22 (m, 3H), 0.943 (t, J = 
8.0 Hz, 9 H), 0.77 – 0.84 (m, 2H), 0.55 (m, 6H); 13C NMR (175 MHz, CDCl3): d 148.0, 
126.2, 45.1, 36.4, 33.5, 26.7, 26.4, 18.6, 17.4, 15.0; IR (thin film): n 2922.4, 2954.2, 
2867.7, 1449.6, 10654, 923, 806.5 cm-1; HRMS (EI+) (m/z): [M-propyl]+ calc for 
C15H29Si, 237.2039; found, 237.2041.  
 
Synthetic Manipulations of Alkenylsilane 12d: 
 
(E)-Non-2-en-1-ylcyclohexane (28) (Scheme 4) 
 
 
 
Alkenylsilane 12d (70 mg, 0.196 mmol) in DMSO (50 µL) was added to a 6 mL dram 
vial with sir bar. TBAF (1.96 mL, 1.96 mmol, 1.0 M in THF) was then slowly added and 
the vessel was subsequently heated at 50 °C for 6 h when the reaction was judged 
complete by TLC analysis. The solvent was removed in vacuo and the crude material was 
purified by flash column chromatography (100 % hexanes) affording a clear oil (35.2 mg, 
86 %) (in >98:2 regiosel, >98:2 d.r.). 1H NMR (500 MHz, CDCl3): δ 5.38 (m, 2H), 1.98 
(m, 2 H), 1.88 (m, 2H), 1.614-1.78 (m, 6H), 1.14 – 1.42 (m, 15H), 0.894 (t, J = 8.7 Hz, 
6H); 13C NMR (175 MHz, CDCl3): δ 131.4, 128.7, 40.7, 38.1, 33.1, 32.6, 31.7, 29.6, 28.8, 
26.6, 26.3, 22.6, 14.1; IR (thin film): ν 2920.3, 2851.3, 1707.9, 1448.0, 1259.5, 966.2 cm-
1; HRMS (EI+) (m/z): [M]+ calc for C15H29, 208.2191; found, 208.2189. 
 
(Z)-(2-Iodonon-2-en-1-yl)cyclohexane (29) (Scheme 4) 
 
 
 
Alkenylsilane 12d (70 mg, 0.196 mmol) in CH3CN (1 mL) was added to a 6 mL dram 
vial equipped with a stir bar. The reaction vessel was cooled in an ice bath to 0 °C and 
then NIS (110 mg, 0.491 mmol) was added. The reaction was then removed from the ice 
bath and warmed to RT. After 12 h the reaction was judged complete by TLC analysis 
and sodium thiosulfate was added (2 mL) to quench the reaction. The solution was then 
extracted with EtOAc (3 X 2 mL) and washed with water (3 X 3 mL) and subsequently 
dried over anhydrous MgSO4. The solvent was then removed in vacuo and the crude 
material was purified by flash column chromatography (100 % hexanes) affording a clear 
oil (50 mg, 77 %) (in >98:2 regiosel., 98:2 d.r.). 1H NMR (500 MHz, CDCl3): δ 6.23 (t, J 
= 8.0 Hz , 0.2H, minor E-isomer), 5.43 (t, J = 7.2 Hz, 1H), 2.32 (d, J = 7.5 Hz, 2H), 2.26 
(d, J = 7.0 Hz , 0.14H, minor E-isomer), 2.09 – 2.16 (m, 2H), 2.04 (q, J = 7.0 Hz, 0.18H), 
1.60 – 1.75 (m, 8H), 1.22 – 1.46 (m, 12H), 1.10-1.19 (m, 1H), 0.90 (t, J = 7.2 Hz, 3H), 
n-HexCy
n-Hex
Cy
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0.84 – 0.88 (m, 2H); 13C NMR ((175 MHz, CDCl3): δ 135.8, 108.2, 52.6, 36.4, 36.3, 32.6, 
31.7, 28.8, 28.4, 26.5, 26.2, 26.1, 22.6, 14.0; IR (thin film): ν 2925.6, 2852.2, 1972.0, 
1718.2, 1449.4, 1249.4, 1118.1, 827.3, 698.5 cm-1; HRMS (EI+) (m/z): [M]+ calc for 
C15H27I, 334.1158; found, 334.1161. 
 
(Z)-1-(4-(1-Cyclohexylnon-2-en-2-yl)phenyl)ethan-1-one (30) (Scheme 4) 
 
 
 
Alkenylsilane 12d (125 mg, 0.7 mmol) in THF (1 mL) was added to a flame-dried 6 mL 
dram vial with a stir bar. TBAF (2.1 mL, 2.1 mmol, 1.0 M in THF) was then slowly 
added followed by addition of 4’-iodoacetophenone (172 mg, 0.7 mmol) and Pd2dba3 (16 
mg, 0.0175 mmol). The reaction vessel was then heated at 50 °C for 30 min when the 
reaction was judged complete by TLC analysis. DCM (1 mL) was added to the vial and 
the solution was filtered with 50 % EtOAc:hexanes and the solvent was removed in 
vacuo. The crude material was purified by flash column chromatography (5 – 15% 
EtOAc:hexanes) affording a clear oil (180 mg, 79 %) (in >98:2 regiosel., >98:2 d.r.). 1H 
NMR (500 MHz, CDCl3): δ 7.90 (d, J = 8.2, 2H), 7.21 (d, J = 8.2 2H), 5.43 (t, J = 7.2 Hz, 
1H), 2.59 (s, 3H), 2.31 (d, J = 7.5 Hz, 2H), 1.89 (q, J = 7.0 Hz, 2H), 1.54 – 1.67 (m, 6H), 
1.14 – 1.34 (m, 10H), 1.00 – 1.11 (m, 5H), 0.824 (t, J = 7.5 Hz, 5H); 13C NMR (175 MHz, 
CDCl3): δ 197.9, 147.0, 138.3, 135.2, 130.0, 128.6, 128.1, 47.2, 35.4, 33.1, 31.6, 30.0, 
28.9, 28.9, 26.6, 26.1, 22.6, 14.0; IR (thin film): ν 2925.3, 1682.0, 1604.1, 1358.0, 1263.3, 
1120.1, 833.1 cm-1; HRMS (ESI+) (m/z): [M+H]+ calc for C23H34O, 327.2682; found, 
327.2682. 
 
Analysis of the crossover experiment: 
 
For detailed experimental crossover studies including an excel spreadsheet for calculating 
ratios of isotopic products, please see Montgomery et. al. 2014 (reference 5). Pure 
samples of products derived from Et3SiH (MW 238), Et3SiD (MW 239), and Pr3SiH 
(MW 280) were independently prepared and GCMS analysis was performed. Based on 
the similarity of the molecular ion minus ethyl regions (M-Et = 209) of the Et3SiH and 
Et3SiD derived product, the molecular ion region of the Pr3SiD derived product was 
assumed to appear as the molecular ion (M = 280) region of the Pr3SiH-derived product, 
shifted by one mass unit. Relative peak heights in the molecular ion minus ethyl region of 
the spectra of each pure compound were normalized, with a value of 1 assigned to the 
base peak. In the crude product of an experiment that employed 0.5 equiv each of Et3SiD 
and Pr3SiH, the ratio of Et3Si products to Pr3Si products was determined by GC. From the 
crude GCMS, the relative intensity of the products were normalized, with the value of 1 
assigned to the base peak. The ratio of the Et3Si-(H) product to Et3Si-(D) product was 
n-HexCy
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determined as follows: 	  
	  	  
X = 1/100 x relative % of Et3Si-(H) product 
         Y = 1/100 x relative % of Et3Si-(D) product = 1-X 	  
In the above equation, after substitution of [1-X] for [Y], the experimental values were 
inserted and the equation was solved for [X]. The ratio of Pr3Si-(H) product to the 
intensity of 280 peak in crossover experiment and Pr3Si-(D) products was determined in a 
similar fashion. Merging the GCFID ratios of Et3Si products to Pr3Si products with the 
data calculated from the above equation, an overall ratio of the products were obtained.   	  
Triethylsilyl : tripropylsilyl product ratios were determined by GC-FID detection and are 
corrected for molecular weight to provide molar ratios. GCMS chromatograms and MS 
spectra for authentic samples and crossover experiments are included as pages S17-S26. 
 
Ratio of Ethyl:Propyl products (nickel crossover): [72:28] 
Ratio of Ethyl:Propyl products (palladium crossover): [38:62] 
 
 
 
 
	  	  
intensity of 209 peak in crossover experiment
intensity of 210 peak in crossover experiment
=
[X] [ rel. height of 209 peak for Et3Si-(H) product] + [Y]  [rel. height of 209 peak for Et3Si-(D) product]
[ rel. height of 210 peak for Et3Si-(H) product] + [Y]  [rel. height of 210 peak for Et3Si-(D) product][X]
Authentic H Sample Authentic D Sample
Ion 209 Ion 210 Ion 209 Ion 210
Crossover Experiment
Ion 209 Ion 210
Calculation Results
% H: % D:
Cy
SiEt3
X
Ni crossover experiment
0 % 100 %1654272 378496 117712 2918912 72912 1783296
Authentic H Sample Authentic D Sample
Ion 280 Ion 281 Ion 280 Ion 281
Crossover Experiment
Ion 280 Ion 281
Calculation Results
% H: % D:
Cy
Si(n-Pr)3
X
Ni crossover experiment
96 % 4 %2186 710 276 1000 2186
Authentic H Sample Authentic D Sample
Ion 209 Ion 210 Ion 209 Ion 210
Crossover Experiment
Ion 209 Ion 210
Calculation Results
% H: % D:
Cy
X
SiEt3
Pd crossover experiment
1 % 99 %285888 56432 17680 1077760 587 21952
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Authentic H Sample Authentic D Sample
Ion 280 Ion 281 Ion 280 Ion 281
Crossover Experiment
Ion 280 Ion 281
Calculation Results
% H: % D:
Cy
X
Si(n-Pr)3
Pd crossover experiment
96 % 4 %53264 12224 154 53264 7333 1956
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Authentic Standards Chromatograms: 	  
	  	  	  	  	  
SiEt3
Cy
H
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SiEt3
Cy
D
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Si(n-Pr)3
Cy
H
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Cy
SiEt3
H
	   S21 
	  	  	  	  	  	  	  	  
Cy
SiEt3
D
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Cy
Si(n-Pr)3
H
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Nickel Crossover Experiment: 
	  	  
 
 
 
SiEt3
Cy
X
Area Ratios
ret. time 9.8 min: 69 %
ret. time 11.9 min: 31 %
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Nickel Crossover Experiment: 
	  	  	  	  
Si(n-Pr)3
Cy
X
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Palladium Crossover Experiment: 
	  
Cy
SiEt3
X
Area Ratios
ret. time 9.9 min: 34 %
ret. time 11.8 min: 66 %
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Palladium Crossover Experiment:
 
 
 
 
 
 
 
Cy
Si(n-Pr)3
X
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